Diversity of rotavirus strains circulating in Haiti before and after introduction of monovalent vaccine.
Haiti
Pre- and post-vaccination
RT-PCR
Rotavirus genotypes
Journal
IJID regions
ISSN: 2772-7076
Titre abrégé: IJID Reg
Pays: England
ID NLM: 9918418183106676
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
16
05
2022
revised:
05
07
2022
accepted:
06
07
2022
entrez:
4
8
2022
pubmed:
5
8
2022
medline:
5
8
2022
Statut:
epublish
Résumé
Haiti introduced a monovalent human group A rotavirus (RVA) vaccine (Rotarix) into its routine infant immunization program in April 2014. The goal of the surveillance program was to characterize RVA strains circulating in Haiti before and after RVA vaccine introduction. Stool samples were collected from children <5 years old presenting with acute gastroenteritis at 16 hospitals in Haiti. RVA antigen enzyme immunoassay (EIA) testing was performed, and G and P genotypes were determined for positive specimens. In this study, genotype data for samples collected from May 2012 through April 2014 (the pre-vaccine introduction era) and May 2014 through July 2019 (post-vaccine introduction era) were analyzed. A total of 809 specimens were tested by the Centers for Disease Control and Prevention. During the pre-vaccine introduction era (May 2012 through April 2014), G12P[8] was the predominant genotype, detected in 88-94% of specimens. There was a high prevalence of the equine-like G3P[8] genotype among Haitian children with RVA after vaccine introduction. The predominance of equine-like G3P[8] in three of five RVA seasons post-vaccine introduction suggests possible vaccine-specific selection pressure in Haiti. These temporal variations in RVA genotype predominance will require continued monitoring in Haiti as the vaccination program continues.
Sections du résumé
Background
UNASSIGNED
Haiti introduced a monovalent human group A rotavirus (RVA) vaccine (Rotarix) into its routine infant immunization program in April 2014. The goal of the surveillance program was to characterize RVA strains circulating in Haiti before and after RVA vaccine introduction.
Methods
UNASSIGNED
Stool samples were collected from children <5 years old presenting with acute gastroenteritis at 16 hospitals in Haiti. RVA antigen enzyme immunoassay (EIA) testing was performed, and G and P genotypes were determined for positive specimens. In this study, genotype data for samples collected from May 2012 through April 2014 (the pre-vaccine introduction era) and May 2014 through July 2019 (post-vaccine introduction era) were analyzed.
Results
UNASSIGNED
A total of 809 specimens were tested by the Centers for Disease Control and Prevention. During the pre-vaccine introduction era (May 2012 through April 2014), G12P[8] was the predominant genotype, detected in 88-94% of specimens. There was a high prevalence of the equine-like G3P[8] genotype among Haitian children with RVA after vaccine introduction.
Conclusions
UNASSIGNED
The predominance of equine-like G3P[8] in three of five RVA seasons post-vaccine introduction suggests possible vaccine-specific selection pressure in Haiti. These temporal variations in RVA genotype predominance will require continued monitoring in Haiti as the vaccination program continues.
Identifiants
pubmed: 35923644
doi: 10.1016/j.ijregi.2022.07.007
pii: S2772-7076(22)00092-3
pmc: PMC9340491
doi:
Types de publication
Journal Article
Langues
eng
Pagination
146-151Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
© 2022 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
Références
Euro Surveill. 2019 Feb;24(6):
pubmed: 30755297
J Infect Dis. 2021 Nov 16;224(9):1539-1549
pubmed: 33822119
Genome Announc. 2017 Nov 22;5(47):
pubmed: 29167260
Nat Rev Dis Primers. 2017 Nov 09;3:17083
pubmed: 29119972
Enferm Infecc Microbiol Clin. 2014 May;32(5):277-9
pubmed: 24684849
Prz Gastroenterol. 2017;12(2):122-127
pubmed: 28702101
J Virol. 2007 Mar;81(5):2382-90
pubmed: 17166908
Pediatr Infect Dis J. 2021 Dec 1;40(12):1135-1143
pubmed: 34870393
J Clin Microbiol. 2021 Oct 19;59(11):e0260220
pubmed: 34432486
Vaccine. 2018 Nov 12;36(47):7238-7242
pubmed: 29371014
Future Microbiol. 2009 Dec;4(10):1303-16
pubmed: 19995190
Am J Trop Med Hyg. 2017 Oct;97(4_Suppl):12-20
pubmed: 29064361
J Infect Dis. 2010 Sep 1;202 Suppl:S34-42
pubmed: 20684715
J Med Virol. 2009 May;81(5):937-51
pubmed: 19319943
Lancet Glob Health. 2019 Jul;7(7):e893-e903
pubmed: 31200889
J Med Virol. 2020 Feb;92(2):174-186
pubmed: 31498444
JAMA Netw Open. 2018 Aug 3;1(4):e181579
pubmed: 30646127
J Gen Virol. 2016 Feb;97(2):403-410
pubmed: 26588920
J Virol Methods. 2015 Oct;223:96-104
pubmed: 26231786
Pathogens. 2020 Jun 27;9(7):
pubmed: 32605014
Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S48-53
pubmed: 21183840
Clin Infect Dis. 2015 Dec 15;61(12):1792-9
pubmed: 26449565
J Virol. 1990 Nov;64(11):5640-4
pubmed: 2170690
Ther Clin Risk Manag. 2008 Feb;4(1):49-63
pubmed: 18728720
Clin Lab Med. 2015 Jun;35(2):363-91
pubmed: 26004648
Infect Genet Evol. 2018 Jul;61:224-228
pubmed: 29614325
Virus Res. 2014 Sep 22;190:75-96
pubmed: 25016036
Am J Trop Med Hyg. 2015 Jul;93(1):54-6
pubmed: 25962775
J Clin Microbiol. 1994 Jul;32(7):1820-2
pubmed: 7929782
J Clin Microbiol. 2013 Sep;51(9):3047-54
pubmed: 23850952
Am J Trop Med Hyg. 2015 Apr;92(4):758-764
pubmed: 25732682
Vaccine. 2012 Apr 27;30 Suppl 1:A122-30
pubmed: 22520121
J Infect Dis. 2020 Oct 13;222(10):1731-1739
pubmed: 32095831
Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S42-7
pubmed: 21183839
Virology. 2019 Aug;534:114-131
pubmed: 31228725
J Clin Microbiol. 1992 Jun;30(6):1365-73
pubmed: 1320625
BMC Infect Dis. 2012 Sep 13;12:213
pubmed: 22974466
Vaccine. 2021 Jul 22;39(32):4458-4462
pubmed: 34187708
Pediatr Infect Dis J. 2015 Oct;34(10):e238-43
pubmed: 26244833
Viruses. 2020 Mar 17;12(3):
pubmed: 32192193
JAMA Pediatr. 2018 Oct 1;172(10):958-965
pubmed: 30105384
J Infect Dis. 2018 Jul 13;218(4):546-554
pubmed: 29790933
PeerJ. 2016 Jan 11;4:e1560
pubmed: 26839745
Arch Virol. 2018 Mar;163(3):791-794
pubmed: 29196818